David L. Marver serves as Executive at Cardiac Science CORP, where they oversee executive responsibilities. Since joining the company, David L. Marver has executed 6 insider transactions totaling $40.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 3, 2010 involved selling 14,315 shares valued at $32.9K.
David L. Marver currently holds 19,275 shares of Cardiac Science CORP (CSCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David L. Marver has been a net buyer of CSCX stock. They have purchased $40.4K and sold $0 worth of shares.
David L. Marver's most recent insider trade was on Dec 3, 2010, when they sold 14,315 shares at $2.30 per share.
Get notified when new Form 4 filings are submitted
| 18,750 |
| $N/A |
| Discretionary |
| Dec 2, 2010 | CSCX | $11.4K | Payment | 4,960 | $2.29 | Discretionary |
| Dec 1, 2010 | CSCX | $31.5K | Tender | 13,675 | $2.30 | Discretionary |
| May 15, 2009 | CSCX | $20.3K | Purchase | 5,000 | $4.05 | Discretionary |
| May 12, 2009 | CSCX | $20.1K | Purchase | 5,000 | $4.03 | Discretionary |